Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Cardiotoxicity 2Breast Neoplasms 2Peripheral Nervous System Diseases 1Cognitive Dysfunction 1

Interventions

Transcranial Direct Current Stimulation 4Walking 2lime 1Ultraviolet Therapy 1Tai Ji 1Sugars 1Standard of Care 1Sodium Chloride 1Silymarin 1Organization and Administration 1Methylphenidate 1Memantine 1Low-Level Light Therapy 1G(M1) Ganglioside 1Equine-Assisted Therapy 1Drug Therapy 1Donepezil 1Docosahexaenoic Acids 1Cognitive Training 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Silymarin × Breast × Clear all
NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Tanta University

Phase 2/3 Unknown
56 enrolled
Breast

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡